ICC results revealed that the expression of hemoglobin-delta and -zeta was increased, and that of CD71, a fetal cell marker transferrin receptor antigen, was also highly elevated in LoVo and Hct116 cells after ATO treatment compared to that in the control cells (Figure 2D). This evidence concerns the gene TFRC and intrahepatic cholangiocarcinoma.